Introduction
Tumour cell specificity is an important prerequisite for successful cancer therapy. The chicken anaemia virus (CAV)-derived protein VP3 (apoptin) has been shown to induce apoptosis in various human tumour and transformed cells (Zhuang et al., 1995a, c; Danen-Van Oorschot et al., 1997) . Apoptosis was detected in virtually all apoptin-expressing tumour cells but not in a range of normal human cell types including blood, fibroblast and epithelial cells (Danen-Van Oorschot et al., 1997) . Coexpression of the SV40 large-T antigen and apoptin was sufficient to induce cell death in normal cells, indicating that even brief expression of this viral transforming gene could make normal cells susceptible to apoptin-induced apoptosis (Noteborn et al., 1998) . Diploid skin fibroblasts from individuals with various hereditary cancer-prone syndromes carrying a germline mutation in a tumour suppressor gene became sensitive to apoptin-induced cell killing after X-ray or UV-C irradiation, while fibroblasts of healthy donors or individuals with DNA repair disorders remained insensitive . The manner by which apoptin is able to distinguish between tumour and normal cells remains to be elucidated. The subcellular localization of apoptin may be important for induction of cell death. In cells resistant to apoptin-mediated cell death the protein had a cytoplasmic localization, whereas in sensitive cells it was found in the nucleus (Noteborn et al., 1994; Zhuang et al., 1995a-c; DanenVan Oorschot et al., 1997) Recently, apoptin was described to be phosphorylated specifically in tumour and transformed cells both in vitro and in vivo. This modification was shown to be important for the nuclear localization and cell killing ability of apoptin (Rohn et al., 2002) .
Apoptin is a 13.6 kDa, serine and threonine rich protein which consists of 121 amino acids (aa) containing two positively charged and two proline rich domains (Noteborn et al., 1991 (Noteborn et al., , 1994 . Apoptin-induced apoptosis occurs independently of the tumour-suppressor gene p53 (Zhuang et al., 1995c) . Furthermore, induction of cell death by apoptin was shown to be independent of oncogene BCR-ABL and stimulated by the antiapoptotic gene Bcl-2 (Zhuang et al., 1995b; Danen-Van Oorschot et al., 1999) . The 19 kDa, antiapoptotic adenovirus E1B protein was found to inhibit apoptininduced apoptosis in a cell type dependent manner (Zhuang et al., 1995b) . However, the mechanisms involved in apoptin-induced cell death are not yet clear. Caspase 3 has been described to be involved in apoptininduced apoptosis, in contrast to the upstream caspases 1 and 8. In addition, apoptin expression was shown to cause the release of cytochrome c from mitochondria, an event often required for activation of downstream caspases (Danen-van Oorschot et al., 2000) .
Recently, several peptides have been identified with the ability to deliver proteins across the cell membrane (Schwarze et al., 2000; Ford et al., 2001) . One of the most commonly used protein transduction systems is a positively charged domain (aa 47-57; YGRKKRRQRRR) found in the HIV-1 trans-activator protein TAT, the TAT protein transduction domain (TAT-PTD). Genes of interest are cloned in-frame with the sequence encoding this domain and isolated as fusion proteins (Nagahara et al., 1998; Becker-Hapak et al., 2001) . TAT-fusion proteins are isolated as urea denatured, high nG proteins that seem to transduce cells more efficiently than lower-energy, correctly folded proteins. Once inside the cell these proteins are believed to be refolded (Nagahara et al., 1998) . Internalization takes place in a rapid, concentration-dependent manner and a maximum intracellular concentration is achieved in less than 20 min (Vives et al., 1997; Nagahara et al., 1998; Gius et al., 1999; Schwarze et al., 1999; VoceroAkbani et al., 1999) . In vivo studies in mice have shown that after intraperitoneal injection of TAT-b-galactosidase enzymatic activity could be detected in all tissues tested, including brain (Schwarze et al., 1999) . Moreover, virtually 100% of the cells in a monolayer exposed to TAT-fusion proteins displayed internalization (Nagahara et al., 1998; Gius et al., 1999; Vocero-Akbani et al., 1999) . Protein transduction can take place at 41C, indicating that receptor-and endocytosis-mediated processes are not involved (Mann and Frankel, 1991; Vives et al., 1997) .
In the present study, we have employed both transgene expression and protein transduction to further investigate the induction of apoptosis by viral protein apoptin. The data presented show that TAT-apoptin efficiently kills human tumour, but not normal cells. However, transfection-mediated expression of apoptin results in the killing of both normal and tumour cell lines examined. The efficiency of apoptin-induced cell death correlated with the level of apoptin expression. The observed colocalization of apoptin and death effector domain proteins such as BCL-10 suggests a possible role for apoptin, analogous to the role of eukaryotic death domain containing proteins.
The fusion of PTD to proteins with tumour cell killing ability and specifically to apoptin, a p53-independent Bcl-2-stimulated inducer of apoptosis, could provide a potential cytotoxic agent for cancer therapy.
Results

Apoptin is initially expressed as cytoplasmic filaments
Apoptin cDNA was generated as described in the material and methods section and cloned into various expression vectors (Figure 1 ). To determine whether the generated apoptin cDNA was expressed and if it was able to induce apoptosis, several cell lines were transfected and microinjected with the pCMV-Ap and pCMV-GFP-Ap plasmids. Analysis by immunofluorescence microscopy revealed that apoptin and GFPapoptin form cytoplasmic filaments resembling actin stress fibres at early stages of expression as shown for Saos-2 cells in Figure 2a . These cytoplasmic filaments were also observed in normal cell lines 1BR3 and 6689 (data not shown). Apoptin cytoplasmic filaments were detectable as early as 6-18 h after microinjection or at 24 h after transfection of DNA into the cells. However, counter-staining of MDCK dog epithelial cells expressing apoptin-filaments with Texas-Red Phalloidin demonstrated no colocalization of apoptin with actin stress fibres. Moreover, apoptin filaments were able to form in the absence of an intact actin stress fibre network as disassembly of stress fibres by treatment with cytochalasin D did not affect the formation of apoptinfilaments (Figure 2b) .
Overexpression of proteins such as FADD and Bcl10 which are involved in Fas or tumour necrosis factor receptor-1 (TNFR1)-mediated apoptosis results in the formation of cytoplasmic structures called death effector filaments (DEFs) (Siegel et al., 1998) . DEFs are formed when proteins containing one or more of the structurally related death domains (DDs), death effector domains (DEDs) or caspase recruitment domains (CARDs), composing the death domain superfamily of proteins, are overexpressed (Weber and Vincenz, 2001) . As the expression of apoptin resulted in the formation of similar cytoplasmic filaments, the association of apoptin with DEFs was investigated. Coexpression of apoptin with either GFP-Bcl10 or FADD-GFP demonstrated clear evidence of the colocalization of apoptin with BCL-10 and its partial colocalization with FADD ( Figure 2c ). 
Apoptin translocates to the nucleus and induces apoptosis
After initial cytoplasmic expression, apoptin was shown to migrate to the nucleus of cells within 48 h after transfection. Apoptosis was observed at this time-point in a subset of Saos-2 osteosarcoma cells which expressed high levels of the protein in their nuclei. DAPI counterstaining of DNA revealed irregular, small nuclei containing condensed chromatin characteristic of apoptotic cells. Expression of apoptin for 5 days resulted in fragmentation of the nuclei into apoptotic bodies ( Figure 3a ). Apoptin expression also induced apoptosis in HeLa cervical carcinoma cells which have previously been reported to be resistant to apoptosis induced by apoptin (Noteborn et al., 1994) . At 5 days posttransfection virtually all HeLa cells expressing apoptin showed clear signs of apoptosis. Interestingly, apoptininduced apoptosis occurred earlier in HeLa cells than in Saos-2 cells. At 2 days post-transfection 69% of the apoptin-expressing HeLa cells displayed signs of apoptosis, compared to 31% of the Saos-2 cells (Figure 3b ). When fused N-terminally to GFP, apoptin retained its ability to migrate to the nucleus and induce apoptosis, as shown in Saos-2 cells at 5 days post-transfection ( Figure 3a) . Although less efficiently than apoptin alone, GFP-apoptin effectively induced apoptosis in Saos-2 cells and H1299 lung carcinoma cells (Figure 3b Figure 3b ). The low efficiency of apoptininduced apoptosis in MCF-7 cells could be due to their lack of caspase-3 activity (Janicke et al., 1998) , which has recently been reported to be a possible requirement for efficient induction of apoptosis by apoptin (Danenvan Oorschot et al., 2000) . One of the downstream substrates of caspase-3 is poly(ADP-ribose) polymerase (PARP). Indirect immunofluorescence staining with an antibody against the 89-kDa fragment of cleaved human PARP detected this fragment exclusively in the apoptotic GFP-apoptin expressing Saos-2 cells (Figure 3c ). Induction of apoptosis was also confirmed by two colour flow cytometric cell cycle analysis. Transfection of H1299 cells with pCMV-Ap resulted in induction of apoptosis in 19% of the total cell population, compared to 6.2% of H1299 cells transfected with the empty pCDNA3.1 vector. Overexpression of wild-type p53 in H1299 cells, which are p53
, resulted in highly efficient induction of apoptosis. The fraction of cells in sub-G1 was 43.2%. Interestingly, the fraction of cells in S phase was also increased with the expression of apoptin (14.2%, compared to 9.1% of the control cells), while the number of cells in G2 phase was comparable in the two cell populations. This result suggests a possible apoptin-induced S phase arrest ( Figure 3d ).
The dynamics of induction of cell death by GFPapoptin was investigated using time-lapse phase-contrast and fluorescence microscopy of Saos-2 cells microinjected in their nuclei with pCMV-GFP-Ap. The live culture was monitored for four days, with images saved at 15 min intervals. For analysis of induction of cell death and cell division, individual positive cells were scored every 24 h. All positive Saos-2 cells expressed GFP-apoptin in the nucleus and showed a decrease in total numbers of approximately 25% over 4 days. Moreover, the fraction of apoptotic-positive cells increased dramatically from 20% at day 1 to 74% at day 4. In contrast, the total number of GFP-expressing Saos-2 cells remained generally constant for at least 4 days after microinjection. GFP protein could be detected in both the nucleus and the cytoplasm of the cells. The fraction of GFP-positive cells that are apoptotic remained approximately 15% until day 3 and then increased slightly at day 4. This raise in the fraction of apoptotic positive cells is most probably due to mild cytotoxicity as a result of very high GFPexpression ( Figure 3e and Supplementary AVI Video Saos2-apoptin).
Nuclear localization is crucial for apoptin-induced apoptosis
The subcellular localization of apoptin has been suggested to be crucial for the induction of apoptosis. In all cells undergoing apoptin-induced apoptosis, the protein was detected in the nucleus. The C-terminus of apoptin has been shown to contain a putative nuclear localization signal (NLS) (Zhuang et al., 1995c) . In order to assess the physiological significance of this domain the 19 aa C-terminal region of apoptin, which includes its NLS, was deleted to generate pCMV-ApDel (Figure 1 ). Transfection studies showed that at 2 days post-transfection this truncated apoptin was expressed in the cytoplasm of the cells. The filamentous expression pattern associated with the expression from pCMV-Ap and pCMV-GFP-Ap was not detected in cells transfected with pCMV-Ap-Del, suggesting that the C-terminus of apoptin may be involved in filamentous distribution. At this time-point, cell killing was not evident. However, at 6 or 7 days post-transfection, apoptin-Del was predominantly present in the nucleus and induction of apoptosis was observed (Figure 4a ), indicating that nuclear localization of apoptin is not exclusively dependent on its putative C-terminal NLS. To further investigate whether nuclear localization is required for induction of apoptosis, apoptin cDNA was cloned in frame with different localization/targeting signals for selective expression in various subcellular compartments (Figure 1 ). Transfection of these constructs into Saos-2 cells resulted in the expression of the apoptin variants either in the nucleus (pEF-Ap and pEF-NU-Ap), mitochondria (pEF-MI-Ap) or endoplasmatic reticulum (pEF-ER-Ap). Apoptin protein expressed from the pEF-Ap construct is not linked to any targeting signal. The presence in the nucleus of the protein expressed from this construct is due to the intrinsic ability of apoptin to travel or be transported to the nucleus. The various targeted apoptins differed in their ability to induce cell death. After 5 days, 48% of cells expressing apoptin from pEF-Ap and 75% expressing pEF-NU-Ap became apoptotic while mitochondrial expression from pEF-MI-Ap resulted in less than 2% apoptosis. ER expression from pEF-ER-Ap resulted in the induction of apoptosis in 29% of apoptin expressing cells. Interestingly, in all these apoptotic cells apoptin had escaped ER retention and was present in the nucleus (Figure 4b ). These results show that nuclear localization of apoptin is required for the induction of apoptosis.
Apoptin expression induces cell death in some normal cells
The reported intrinsic tumour-and transformed cell specificity of apoptin-induced apoptosis was investigated by direct comparison of apoptin-mediated induction of apoptosis in 1BR3 human primary fibroblasts and their SV-40 large-T antigen transformed counterparts 1BR3N using apoptin and GFP-apoptin cDNA. Unexpectedly, in both cells apoptin and GFP-apoptin were observed to be located predominantly in the nucleus of all expressing cells. Moreover, both apoptin and GFP-apoptin expression induced apoptosis in normal cells which was apparent from nuclease morphology obtained by DAPI counterstaining (Figure 5a ). Another cell line, 6689, a secondary culture of nonimmortalized human fetal lung fibroblasts, was also efficiently killed by the expression of apoptin cDNA (Figure 5a ). At 5 days post-transfection the efficiency of induction of cell death in normal 1BR3 and 6689 cells by apoptin or GFP-apoptin was comparable to transformed 1BR3N and cancer cell lines Saos-2 and H1299. Induction of apoptosis was confirmed by the detection Efficient delivery and induction of apoptosis by TAT-apoptin L Guelen et al of the 89-kDa PARP fragment in apoptin-positive 6689 cells (Figure 5b ).
The effect of apoptin expression on the viability of 6689 cells was investigated using time-lapse phasecontrast and fluorescence microscopy, as described earlier for Saos-2 cells. Expression of GFP-apoptin after microinjection of plasmid DNA into the nucleus of 6689 cells resulted in predominant nuclear localization of the protein in all positive cells. Moreover, GFPapoptin caused efficient induction of apoptosis in these cells. The total number of GFP-apoptin expressing cells dropped dramatically to below 50%, while after 4 days almost all the positive cells had an apoptotic phenotype.
No increase in induction of apoptosis could be detected as a result of expression of GFP alone. The total number of GFP-expressing cells increased as a result of proliferation of positive cells (Figure 5c and Supplementary AVI Video 6689-apoptin). Time-lapse fluorescence microscopy of high-level expressing MDCK nontransformed dog epithelial cells microinjected with pCMV-GFP-Ap also revealed nuclear expression of the fusion protein and rapid induction of cell death. After 4 h expression time images were saved at 5 min intervals for 22 h. Evidence of dense nuclear condensation with subsequent cell death could be observed as early as 10 h after microinjection (data not shown). The efficiency of apoptin-induced apoptosis depends on the protein expression level
Saos-2 cells transfected with pCMV-Ap showed higher levels of protein than those transfected with pEF-Ap. The characteristic cytoplasmic filaments, observed at early stages after transfection and microinjection of cells with pCMV-Ap and pCMV-GFP-Ap, were not detected after transfection with pEF-Ap, suggesting that the formation of the filaments may be dependent on the intracellular levels of apoptin. Furthermore, at 5 days post-transfection all the cells expressing apoptin from pEF-Ap showed nuclear localization of the protein but only 48% had an apoptotic phenotype while the higher level of apoptin from the CMV promoter resulted in apoptosis in virtually 100% of apoptin-positive cells (Figure 6a ). In order to obtain different cellular levels of apoptin, H1299 cells were transfected with a serial dilution of pCMV-GFP-Ap plasmid. The total amount of DNA transfected into cells was equilibrated using empty vector DNA. Using 50-400 ng pCMV-GFP-Ap had no significant effect on the induction of apoptosis while using 25-10 ng reduced the number of apoptotic cells by 50% (Figure 6b ). This effect could further be observed in a population of H1299 cells which expressed different Survival curves of Saos-2 cells which were microinjected with 5 mg/ml or 25 mg/ml pCMV-GFP-Ap. The live culture was monitored from 18 h post-microinjection for 4 days by using time-lapse phase-contrast and fluorescence microscopy. Digital images were saved at 15 min intervals. Individual positive cells were followed during the whole sequence and time of division or death was recorded. The rate of cell killing in both populations is indistinguishable. Cells injected with 5 mg/ml DNA dose show on average about 20% higher survival than those injected with 25 mg/ml DNA Efficient delivery and induction of apoptosis by TAT-apoptin L Guelen et al apoptosis. Analysis of the survival curves demonstrated that the rate of induction of apoptosis was very similar in the two cell populations. However, there was a clear difference in the fraction of apoptin-expressing surviving cells between the two DNA concentrations at any point during the sequence of the time-lapse analysis. Cells injected with the smaller DNA dose showed on average about 20% higher survival than those injected with 25 mg/ml DNA (see Figure 6d) . These results suggest that the intracellular level of apoptin is an important determinant of its ability to induce apoptosis and that there may be a protein concentration threshold below which apoptosis is not induced.
TAT-apoptin transduces cells with high efficiency
To achieve very efficient delivery of apoptin, while closely controlling the dosage, we used the highly efficient HIV-TAT-mediated protein transduction system. Apoptin was fused to TAT-PTD using pTAT-HA plasmid. From this vector proteins are expressed in frame with a 6-histidine leader peptide, followed by the 11 aa TAT-PTD, flanked by glycine residues (for free rotation of the domain), and a hemagglutinin tag (Nagahara et al., 1998) . TAT-apoptin and TAT-GFP proteins were isolated from bacteria as described in the materials and methods section. Samples of isolated proteins were checked by SDS-PAGE, followed by Coomassie staining and were shown to contain the proteins of the expected size. Western blot analysis using mouse anti-VP3 monoclonal antibody confirmed that the isolated protein was TAT-apoptin (data not shown). Saos-2 and HSC-3 human head and neck tumour cells were treated with 1 mM TAT-apoptin or TAT-GFP. Within 30 min of addition the internalization of these proteins was observed in virtually 100% of the cells in culture (Figure 7a ). Addition of lower concentrations of TAT-apoptin (400 or 200 nM) to Saos-2 cells also resulted in lower intracellular levels of the protein, but still virtually 100% of the cells were found to be transduced (data not shown). At 30 min post-transduction TAT-apoptin appeared to have a granular pattern in Saos-2 cells, while in HSC-3 it was more diffused. At this time-point, TAT-apoptin was mainly localized to the cytoplasm of both cell types, while TAT-GFP was present in both the cytoplasm and the nucleus. Counterstaining of the DNA with DAPI indicated that cell viability was not affected by TAT-apoptin or TAT-GFP at 30 min (Figure 7a ).
TAT-apoptin translocates to the nucleus and induces apoptosis in cancer cells
Exposure of Saos-2 and HSC-3 cells to TAT-apoptin for 24 h resulted in the translocation of apoptin from the cytoplasm to the nuclear and perinuclear cellular compartments. In contrast, the subcellular localization of TAT-GFP did not change from that observed after 30 min (Figure 7b ). These results indicate that TATapoptin retains its ability to travel or to be transported to the nucleus of the cell, an essential requirement for apoptin-induced apoptosis. In contrast to cancer cells, in 6689 and 1BR3 normal cells TAT-apoptin remained in the cytoplasm while TAT-GFP showed a clear nuclear and cytoplasmic localization pattern similar to that observed in the tumour cells. Furthermore, at this timepoint DAPI-staining indicated the induction of apoptosis in a subset of TAT-apoptin positive Saos-2 and HSC-3 cells, particularly in cells displaying high levels of nuclear or perinuclear TAT-apoptin, while no signs of apoptosis were observed in 6689 and 1BR3 normal fibroblasts containing TAT-apoptin. This effect was apoptin specific as no increase in the induction of apoptosis was detected in any of the cell types transduced with TAT-GFP (Figure 7b ). At 5 days post-transduction, TAT-apoptin was still detectable in a subset of Saos-2 and 6689 cells. Induction of apoptosis was exclusively observed in the Saos-2 cells showing high levels of TAT-apoptin in their nucleus. In 6689 cells apoptin remained in the cytoplasm and no apoptosis was detected. TAT-GFP could be detected in these cells at 5 days post-transduction without any sign of apoptosis ( Figure 7c ).
Discussion
Previous studies have shown that apoptin has the ability to induce apoptosis specifically in tumour cells. Apoptin was found to be located in the cytoplasm of normal cells while in tumour cells it was localized mainly in the nucleus (Danen-Van Oorschot et al., 1997). These differences in localization were suggested to be the main mechanism by which normal cells show resistance to apoptin-mediated cell killing. We have generated apoptin and GFP-apoptin cDNAs. In all cells in which apoptin or GFP-apoptin was expressed, the proteins were initially located in the cytoplasm in a characteristic filamentous structure. The actin cytoskeleton has been shown to play a pivotal role in regulating the morphologic and phenotypic events of a malignant cell (Holme, 1990) . One common feature of malignant cells seems to be the loss of intact actin cytoskeleton. We therefore investigated whether the observed apoptin filaments were associated with the actin cytoskeleton. Immunofluorescence studies of cells treated with cytochalasin D showed that apoptinfilaments were neither colocalized nor dependent on an intact actin structure. Furthermore, the Apoptin-filaments resembled the cytoplasmic structures formed by DEFs (Siegel et al., 1998) , and therefore the association of Apoptin with such factors was investigated. When coexpressed with members of the death domain superfamily Apoptin was found colocalized with the CARD containing protein Bcl10 and showed partial colocalization with the DD containing protein FADD. Apoptin colocalization with other death domain superfamily proteins and the putative physiological significance of this occurrence are currently being investigated.
Following the initial filamentous expression pattern both apoptin and GFP-apoptin translocated to the Efficient delivery and induction of apoptosis by TAT-apoptin L Guelen et al nucleus, which was found to be essential for apoptin to be able to induce apoptosis. In some cells, apoptin and GFP-apoptin were present at high levels in the nucleoli (data not shown). Transcription of ribosomal RNA and assembly of ribosomal subunits takes place in these highly organized subcompartments of the nucleus. Induction of apoptosis by apoptin may therefore be due to interference with the ribosome synthesis process resulting in the shutting down of the cellular biosynthetic activities leading to cell death. It has been shown that during apoptosis the proteinsynthesis rate decreases. However, the timing of this event in the apoptotic process is still unclear (Cohen, 1993) . In addition, apoptin was sometimes present in the nucleus in a granular expression pattern that colocalizes with DNA. Putatively, apoptin can act as a suppressor or enhancer of transcription of genes involved in the prevention or execution of apoptosis. However, apoptin expression did not have an effect on the activity of the promoters of various genes known to be involved in apoptosis, such as Bax, MDM2, Noxa, PiDD, Pig3 and p21/Waf1 (data not shown).
Recently the C-terminus of apoptin has been described to contain a bipartite-type nuclear localization signal at aa 82-88 (NLS1) and 111-121 (NLS2) (DanenVan Oorschot et al., 2003) . Deletion of the aa 111-121 containing NLS2 was shown to significantly decrease nuclear localization suggesting this domain to be involved in nuclear targeting (Zhuang et al., 1995c) . However, our data show that NLS2 is not essential for nuclear localization as a mutant lacking this domain was still able to translocate into the nuclei of different cell types and induce apoptosis. The complete abolition of nuclear transport may therefore require the deletion of both NLS1 and NLS2. Expression of apoptin-variants fused to localization signals for different subcellular compartments showed that nuclear localization is required for induction of cell death. Targeting apoptin to the mitochondria resulted in almost complete abolishment of its ability to induce apoptosis. However, immunofluorescence studies showed that the expression level of the mitochondrial apoptin variant is low, which may be a factor in its reduced potential to kill cells. Targeting apoptin to the endoplasmatic reticulum resulted in high expression levels but significantly reduced cytotoxic activity of the protein. It has recently been shown that a cellular kinase phosphorylates apoptin on threonine 108 specifically in tumour cells. Phosphorylation of this residue was shown to be required for apoptin's ability to translocate to the nucleus and to induce apoptosis (Rohn et al., 2002) . However, in our pCMV-Ap-Del construct this residue was deleted while its product was still able to translocate to the nucleus and induce apoptosis.
Using both transfection and microinjection techniques for plasmid DNA transfer we established that, in addition to tumour and transformed cells, 1BR3 normal human diploid fibroblasts and the early passage secondary culture of normal human embryonal lung fibroblasts 6689 are both sensitive to cell death induced by apoptin and GFP-apoptin. In addition, time-lapse fluorescence microscopy of nontransformed MDCK dog epithelial cells and normal fibroblasts expressing GFP-apoptin revealed that the fusion protein was able to induce rapid cell death in these cells. As was observed in tumour and transformed cells, apoptin and GFPapoptin were predominantly located in the nucleus of these normal cells.
Induction of apoptosis by apoptin occurs very quickly in some cell types (2-3 days in HeLa cells). However, in other cell types, such as Saos-2 cells, apoptosis is not induced until 5-7 days after transfection. These data suggest that cellular proliferation and hence cell cycling time may affect the rate by which apoptin induces cell death. Indeed we observed a correlation between a high cellular proliferation rate and the efficiency of apoptininduced apoptosis as fast growing cancer cell lines HeLa and H1299 with a population doubling time (PDT) of about 31 and 18 h respectively were killed significantly faster than slow growing cells such as Saos-2 with a PDT of 48 h (data not shown). FACS analysis showed that as well as an increase in sub-G1 population apoptinexpressing cells had a higher S phase ratio, suggesting the possibility of S phase arrest. Moreover, time-lapse phase-contrast and fluorescence microscopy revealed that both Saos-2 and 6689 cells microinjected with pCMV-GFP-Ap had nearly completely lost the ability to divide, as compared to cells microinjected with pCMV-GFP (data not shown). Apoptin may execute its function when the cell is undergoing mitosis, making fast proliferating cells more sensitive to apoptin-induced apoptosis. Although putative preferential killing of fast proliferating cells by apoptin may be exploited in developing new cancer gene therapy strategies, this will be hampered by the demonstrated sensitivity of various normal cells to the expression of this protein.
Induction of apoptosis was observed to be dependent on the intracellular level of apoptin. There appears to be a protein concentration threshold above which apoptin is able to induce apoptosis. This concentration threshold may vary between different cell lines. Expression of apoptin by transfection or microinjection may yield protein levels exceeding the threshold below which the normal cells used in our study remain resistant to apoptin-mediated induction of apoptosis. Remarkably, apoptosis of normal cells was not observed when apoptin protein was delivered as a TAT-apoptin fusion. TAT-apoptin, when added to the culture media, was able to traverse the cytoplasmic membrane and was delivered to virtually all normal and tumour cells in a monolayer culture. TAT-apoptin was shown to be capable of translocating to the nucleus and inducing apoptosis in tumour cells. TAT-apoptin remained cytoplasmic in normal cells and there was no induction of apoptosis above background levels observed. The resistance of the normal cells to apoptosis induced by TAT-apoptin may be the consequence of lower intracellular apoptin levels achieved using protein transduction, as compared to transgene expression. Additionally, in transfection and microinjection experiments the introduction of DNA into the cytoplasm or nucleus possibly activates cellular stress pathways that lead to an increase in induction of apoptosis. However, no such effect was observed in cells in which GFP was expressed.
In conclusion, these studies demonstrate the efficiency of TAT-mediated transduction of apoptin into both normal and tumour cells. TAT-apoptin retains the characteristic expression pattern of apoptin as demonstrated by its nuclear translocation in the malignantly transformed but not in the normal cells. TAT-apoptin is also functionally active and can efficiently induce tumour cell apoptosis. These studies also show the importance of apoptin protein level on the specificity of its toxicity to tumour cells. This is not surprising as high levels of apoptin may overcome the equilibrium between apoptin and other cellular components which are involved in the retention of apoptin to the cytoplasm and hence inhibition of its apoptotic activity in normal cells. However, there are still a large number of outstanding questions regarding both the mode of action and the tumour specificity of apoptin. Important amongst these are the significance of its phosphorylation at aa 108 and its cellular/subcellular concentration both for induction of apoptosis and for its specificity to tumour cells. Particularly important for the development of apoptin-based therapeutic strategies is the as yet undetermined incremental difference in the level of apoptin that is required for tumour-specific induction of apoptosis.
Materials and methods
Generation and cloning of apoptin
The VP3 gene was amplified by PCR on pCAA-3 plasmid, composed of three tandemly repeated CAV Replicative Forms, cloned into the PstI site of pGEM (Meehan et al., 1992) . Using this PCR product as a template the nucleotides mismatching with apoptin were changed into the apoptin sequence by the PCR overlapping extension technique. The obtained product was cloned into pcDNA3.1, pEF/myc/cyto, pEF/myc/ER, pEF/myc/mito and pEF/myc/nuc (All Invitrogen Life Technologies), pEGFP-C1 (Clontech) and pTAT-HA. An apoptin variant with a 3 0 -terminal 57 base-pairs deletion (apoptin-Del) was generated by PCR using apoptin as the template and introducing a stop codon at position 307. This product was cloned into pcDNA3.1. The final constructs, pCMV-Ap, pCMV-Ap-Del, pEF-Ap, pEF-ER-Ap, pEF-MI-Ap, pEF-NU-Ap pCMV-GFP-Ap (Figure 1 ) and pTAT-HA were analysed by digestion reactions and DNA sequencing (Cytomyx, Cambridge).
Cell lines and cell culture
Saos-2 human osteosarcoma cells, HeLa human adenocarcinoma cells, H1299 human nonsmall cell lung carcinoma cells, MCF-7 human breast cancer cells, HSC-3 human oral cancer cells, 6689, an early passage secondary culture of normal human embryonal lung fibroblasts, and MDCK dog epithelial cells were maintained in DMEM, supplemented with 10% foetal calf serum and 1 mM sodium pyruvate, 2.5 mg/ml streptomycin and 5 mg/ml penicillin (All Sigma). 1BR3 normal and the SV-40 transformed 1BR3N human fibroblasts were grown in the same medium, containing 15% foetal calf serum.
All cells were grown in a 95% air, 5% CO 2 humidified incubator at 371C.
Transient transfection and fluorescence microscopy
At 1 day prior to transfection, cells were seeded in 60 mm tissue culture dishes and transfected at 50-80% confluency by calcium-phosphate-DNA co-precipitation using 5 mg plasmid DNA (Flinterman et al., 2003) . Alternatively, cells were seeded in Falcon eight-well culture slides (Becton Dickinson). In each well, the cells were transfected at 50-80% confluency with 400 ng plasmid DNA preincubated with 1.4 ml LipofectA-MINE 2000t Reagent (Life Technologies), according to the manufacturer's protocol. At various time-points post-transfection, the cells growing in 60 mm tissue culture dishes were harvested by trypsinization and resuspended in PBS. Cell suspensions were centrifuged on slides using a Shandon Cytospin and fixed by incubation in acetone for 20 min at À201C. Cells growing in Falcon eight-well culture slides were washed in PBS and directly fixed in acetone for 20 min at -201C. Apoptin-expression was detected with mouse anti-VP3 monoclonal antibody (kindly provided by Dr D. Todd), followed by goat anti-mouse fluorescein isothiocyanate (FITC) conjugated antibody (Sigma). Cells were mounted in Vectashield mounting medium (Vector Laboratories) containing 2,4-diamidino-2-phenylindole (DAPI), for detection of cell death. Cells transfected with the pCMV-GFP-Ap construct were fixed in 2% paraformaldehyde for 15 min at RT, washed in PBS and mounted. The cells were visualized using the Olympus AX70 fluorescence microscope at high power ( Â 1000) and positive cells undergoing cell death were scored at Â 400.
Flow cytometric cell cycle analysis
Transfected cells were harvested by trypsinization and centrifugation at 200 g and fixed in 70% ethanol. Total cell protein was stained with 5 mg/ml FITC and DNA was stained with 40 mg/ml propidium iodide (PI) in PBS containing 500 mg/ ml RNAse A (all Sigma). Two colour cell cycle analysis was performed using a FACSCalibur Flow Cytometer (BD Bioscience). Doublets of cells in G1, as determined by FITC staining, were excluded from the analysis, because they can contaminate the G2 fraction.
Microinjection
One day prior to microinjection, cells were seeded in 60 mm glass-bottomed culture dishes (MatTek Corp., USA) in their normal culture medium. Groups of cells were microinjected in the nucleus with plasmid DNA diluted with PBS to a final concentration ranging from 5 to 50 mg/ml. Injections were performed using a Zeiss-Eppendorf microinjection workstation.
Confocal microscopy
Microinjected cells were fixed and stained in situ on culture dishes, and mounted beneath a glass cover slip in Mowiol mountant containing 0.01%. p-phenelenediamine (PPD) as an antiquenching agent. Fluorescence images were recorded on a BioRad MRC 1024 confocal imaging system equipped with krypton-argon laser and Nikon Eclipse E600 microscope and Â 60 Plan-Apo objective.
Time-lapse fluorescence microscopy
Cells growing on plastic Petri dishes in DMEM þ 10% FCS were microinjected at approximately 25% confluence with Efficient delivery and induction of apoptosis by TAT-apoptin L Guelen et al pCMV-GFP or pCMV-GFP-Ap. Filming commenced at 18 h after microinjection on a Multisite Time-Lapse imaging system for a further 78 h using Compix 'Simple PCI' image capture software in an atmosphere of 371C and 10% CO 2 . Sequentional phase contrast and GFP-fluorescence was detected using a 100 W xenon lamp with FITC filter set. Digital images were captured at 15 min intervals using a Â 10 objective.
Protein isolation and protein transduction
The TAT-apoptin expressing plasmid pTAT-Ap and the TAT-GFP-encoding pTAT-HA-GFP plasmid were transformed into chemically competent E. coli BL21(DE3)pLysS cells (Novagen). For protein isolation, a single colony was expanded and bacteria were harvested by centrifugation. Cell pellets were re-suspended in 10 ml Buffer Z (8 M urea/100 mM NaCl/20 mM HEPES, pH 7.0) and sonicated on ice with three pulses of 15 s each. Cell debris was removed by centrifugation at 20 000 g for 10 min at 41C. TAT-fusion proteins in Buffer Z with 10 mM imidazole were isolated by Ni-ion affinity chromatography (Amersham Pharmacia Biotech) and elution in Buffer Z with increasing imidazole concentrations (100, 250 and 500 mM). Urea was removed by elution through PD-10 desalting columns (Amersham Pharmacia Biotech) using PBS/ 10% glycerol in the presence of protease inhibitors (Complete, Mini, Roche). The isolation procedure was monitored by mixing protein samples 5 : 1 with Bradford reagent (BioRad) and measuring the protein concentration at 595 nM using the BioRad Model 3550 Microplate reader. Cells were seeded in Falcon eight-well culture slides and transduced at 50-80% confluence with various concentrations of TAT-fusion proteins in the culture medium. Cells were fixed, stained and mounted as described.
Cell proliferation rate
After seeding 5 Â 10 4 À1 Â 10 5 cells per well in six-wells tissue culture dishes they were harvested by trypsinization and counted at 24 h intervals for at least 5 days using a hematocytometer. Experiments were carried out in triplicate. Statistical analysis and calculation of the population doubling time were performed using the GraphPad Prism program.
